Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Xiao, Liang ^a   Fu, Zhi ren ^a   Liu, Fang ^a   Zhang, Lu ding ^a   Shi, Xiao min ^a   Shen, Xiao yun ^b   Ni, Zhi jia ^a   Fu, Hong ^a   Li, Rui dong ^a   Cao, Xue tao ^b   Ding, Guo shan ^a   Wang, Quan xing ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; KIDNEY INJURY MOLECULE 1 IMMUNOGLOBULIN FC FRAGMENT FUSION PROTEIN; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MONOCLONAL ANTIBODY; PROTEIN KINASE B; RECOMBINANT PROTEIN; T CELL IMMUNOGLOBULIN MUCIN 4; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HAVCR1 PROTEIN, HUMAN; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE 3; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS LINKING; DENDRITIC CELL; DOWN REGULATION; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; EFFECTOR CELL; ENZYME PHOSPHORYLATION; GRAFT SURVIVAL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ALLOTRANSPLANTATION; ANIMAL; BAGG ALBINO MOUSE; C3H MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; FLOW CYTOMETRY; GENETICS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

MUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN FC FRAGMENTS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959988692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021697     Document Type: Article

References (39)

1. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ, (2003) The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 3: 454-462.
2. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK, (2005) The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 11: 362-369.
3. Su EW, Lin JY, Kane LP, (2008) TIM-1 and TIM-3 proteins in immune regulation. Cytokine 44: 9-13.
4. Meyers JH, Chakravarti S, Schlesinger D, Illes Z, Waldner H, et al. (2005) TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol 6: 455-464.
5. Umetsu SE, Lee WL, McIntire JJ, Downey L, Sanjanwala B, et al. (2005) TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 6: 447-454.
6. Rodriguez-Manzanet R, Meyers JH, Balasubramanian S, Slavik J, Kassam N, et al. (2008) TIM-4 expressed on APCs induces T cell expansion and survival. J Immunol 180: 4706-4713.
7. Binne LL, Scott ML, Rennert PD, (2007) Human TIM-1 associates with the TCR complex and up-regulates T cell activation signals. J Immunol 178: 4342-4350.
8. Kim HS, Kim HS, Lee CW, Chung DH, (2010) T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol 184: 4095-4106.
9. Mariat C, Degauque N, Balasubramanian S, Kenny J, DeKruyff RH, et al. (2009) Tim-1 signaling substitutes for conventional signal 1 and requires costimulation to induce T cell proliferation. J Immunol 182: 1379-1385.
10. Mizui M, Shikina T, Arase H, Suzuki K, Yasui T, et al. (2008) Bimodal regulation of T cell-mediated immune responses by TIM-4. Int Immunol 20: 695-708.
11. Xiao S, Najafian N, Reddy J, Albin M, Zhu C, et al. (2007) Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function. J Exp Med 204: 1691-1702.
12. Degauque N, Mariat C, Kenny J, Zhang D, Gao W, et al. (2008) Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest 118: 735-741.
13. Encinas JA, Janssen EM, Weiner DB, Calarota SA, Nieto D, et al. (2005) Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma. J Allergy Clin Immunol 116: 1343-1349.
14. Wang Q, Liu Y, Wang J, Ding G, Zhang W, et al. (2006) Induction of allospecific tolerance by immature dendritic cells genetically modified to express soluble TNF receptor. J Immunol 177: 2175-2185.
15. Bayer AL, Jones M, Chirinos J, de Armas L, Schreiber TH, et al. (2009) Host CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCT. Blood 113: 733-743.
16. Thorborn G, Pomeroy L, Isohanni H, Perry M, Peters B, et al. Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection. PLoS One 5: e9254.
17. Chen W, Jin W, Hardegen N, Lei KJ, Li L, et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198: 1875-1886.
18. Song S, Shen X, Tang Y, Wang Z, Guo W, et al. (2010) Sinomenine pretreatment attenuates cold ischemia/reperfusion injury in rats: the role of heme oxygenase-1. Int Immunopharmacol 10: 679-684.
19. An H, Hou J, Zhou J, Zhao W, Xu H, et al. (2008) Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 9: 542-550.
20. Wang Q, Liu Y, Li XK, (2005) Simplified technique for heterotopic vascularized cervical heart transplantation in mice. Microsurgery 25: 76-79.
21. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Kramer JM, Kochinke K, Oortveld MA, Marks H, Kramer D, et al. (2011) Epigenetic regulation of learning and memory by Drosophila EHMT/G9a. PLoS Biol 9: e1000569.
23. Ueno T, Habicht A, Clarkson MR, Albin MJ, Yamaura K, et al. (2008) The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest 118: 742-751.
24. Reynolds LF, de Bettignies C, Norton T, Beeser A, Chernoff J, et al. (2004) Vav1 transduces T cell receptor signals to the activation of the Ras/ERK pathway via LAT, Sos, and RasGRP1. J Biol Chem 279: 18239-18246.
25. Delgado P, Fernandez E, Dave V, Kappes D, Alarcon B, (2000) CD3delta couples T-cell receptor signalling to ERK activation and thymocyte positive selection. Nature 406: 426-430.
26. Rathmell JC, Elstrom RL, Cinalli RM, Thompson CB, (2003) Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur J Immunol 33: 2223-2232.
27. Jacobs SR, Herman CE, Maciver NJ, Wofford JA, Wieman HL, et al. (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180: 4476-4486.
28. Mariat C, Degauque N, Strom TB, (2009) TIM-1: a new player in transplant immunity. Transplantation 87: S84-86.
29. Racioppi L, Ronchese F, Matis LA, Germain RN, (1993) Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med 177: 1047-1060.
30. Mesri M, Smithson G, Ghatpande A, Chapoval A, Shenoy S, et al. (2006) Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins. Int Immunol 18: 473-484.
31. Yang PC, Xing Z, Berin CM, Soderholm JD, Feng BS, et al. (2007) TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterology 133: 1522-1533.
32. Xie A, Wang S, Zhang K, Wang G, Ye P, et al. (2011) Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection. Transplantation 91: 27-34.
33. Pietra BA, Wiseman A, Bolwerk A, Rizeq M, Gill RG, (2000) CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. J Clin Invest 106: 1003-1010.
34. Grazia TJ, Pietra BA, Johnson ZA, Kelly BP, Plenter RJ, et al. (2004) A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol 172: 7451-7458.
35. Kobayashi N, Karisola P, Pena-Cruz V, Dorfman DM, Jinushi M, et al. (2007) TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27: 927-940.
36. Yamanishi Y, Kitaura J, Izawa K, Kaitani A, Komeno Y, et al. (2010) TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury. J Exp Med 207: 1501-1511.
37. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, et al. (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135-4142.
38. Izawa K, Kitaura J, Yamanishi Y, Matsuoka T, Oki T, et al. (2007) Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3. J Biol Chem 282: 17997-18008.
39. Yamanishi Y, Kitaura J, Izawa K, Matsuoka T, Oki T, et al. (2008) Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells. Blood 111: 688-698.